Japan, July 1 -- JOHNS HOPKINS UNIV has got intellectual property rights for 'PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED HIGH-AFFINITY AGENTS FOR ENDORADIOTHERAPY OF PROSTATE CANCER.' Other related details are as follows:
Application Number: JP,2024-221155
Category (FI): C07D257/02,A61P13/08,A61K47/54,C07D401/12,A61K31/555,A61K51/04,A61K51/02,100,A61P35/00,A61K51/04,100
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Dec. 17, 2024
Publication Date: March 26, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
